Please assess the completion status of the following clinical trial:

Trial Title: The Effectiveness and Safety of Gabapentin for Post-operative Pain After Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women undergoing elective cesarean delivery~Exclusion Criteria:~* Patients unable to communicate in English~* Patients with an American Society of Anesthesiologists (ASA) classification of 3 or higher~* Patients with contraindications to any of the medications used in the study~* Patients with contraindications to spinal anesthesia~* Patients who have taken any pain medication in the past week~* Patients with fetuses having congenital abnormalities~* Patients with severe mental disorders~* Patients with HIV or hepatitis infections~* Intravenous drug users~* Patients with uncontrolled hypertension and diabetes~* Patients with central nervous system tumours

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Gabapentin
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).